GlassScriptPhysician profile
Danny Trew Deckard
NPI 1386973451
$100,647.92
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20K · 2022: $28K · 2023: $48K · 2024: $4,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Travel and Lodging: $11K · Food and Beverage: $3,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,930.00 |
| Travel and Lodging | $11,358.65 |
| Food and Beverage | $3,762.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $38,637.11 | 2021-2023 | Apretude, Dovato, Cabenuva |
| Gilead Sciences, INC. | $36,418.98 | 2021-2023 | Descovy, Biktarvy |
| Emd Serono, INC. | $8,174.41 | 2022-2024 | Serostim, Serostim |
| Merck Sharp & Dohme LLC | $7,862.49 | 2021-2023 | Pifeltro, Delstrigo |
| Janssen Scientific Affairs, LLC | $5,714.42 | 2021-2023 | Symtuza |
| Janssen Products, LP | $1,156.49 | 2021-2022 | |
| Theratechnologies INC. | $919.49 | 2021-2023 | Egrifta, Trogarzo |
| Novo Nordisk INC | $279.20 | 2021-2023 | Ozempic, Rybelsus, Wegovy |
| Janssen Biotech, INC. | $228.23 | 2021-2023 | Symtuza |
| Astrazeneca Pharmaceuticals LP | $162.98 | 2021-2023 | Farxiga |
| Napo Pharmaceuticals INC | $141.75 | 2021-2023 | Mytesi |
| Abbvie INC. | $138.79 | 2021-2023 | |
| Lilly USA, LLC | $107.75 | 2021-2023 | Mounjaro, Emgality, Jardiance |
| Antares Pharma, INC. | $95.64 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Biohaven Pharmaceuticals, INC. | $75.63 | 2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Deckard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.